You just read:

AbbVie receives a positive recommendation from the CADTH Canadian Drug Expert Committee for MAVIRET™ - an oral therapy for the treatment of patients with hepatitis C

News provided by

AbbVie Canada

Feb 06, 2018, 09:00 ET